Inhibikase Therapeutics IKT Q1 2026 Earnings Narrowing Losses as Pipeline Progress Takes Center Stage ATLO Q1 2026 Earnings EPS Beats Estimates by Nearly 6 RRGB Q1 2026 Earnings Surprise Profit Beats Estimates by a Wide Margin BNAI Q3 2025 Earnings EPS Beat Mitigates Revenue Absence Stock Declines 367 PAPL Q3 2025 Earnings EPS Surprises Positively Despite Revenue Uncertainty Stock Declines Bridgewater Bancshares BWB Q1 2026 Earnings Marginal EPS Miss Amid Positive Market Response